179 related articles for article (PubMed ID: 38449852)
21. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
22. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
Song Z; Zou L
Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
[TBL] [Abstract][Full Text] [Related]
23. Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus.
Thapi S; Baeg K; Kim MK; Gallagher EJ
Pancreas; 2021 Oct; 50(9):1293-1297. PubMed ID: 34860814
[TBL] [Abstract][Full Text] [Related]
24. Constructing and validating nomograms to predict risk and prognostic factors of distant metastasis in urothelial bladder cancer patients: a population-based retrospective study.
Chen D; Luo Z; Ye C; Luo Q; Fan W; Chen C; Liu G
BMC Urol; 2022 Dec; 22(1):212. PubMed ID: 36575440
[TBL] [Abstract][Full Text] [Related]
25. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study.
Pan M; Yang Y; Teng T; Lu F; Chen Y; Huang H
BMC Gastroenterol; 2021 Mar; 21(1):101. PubMed ID: 33663420
[TBL] [Abstract][Full Text] [Related]
27. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
Front Public Health; 2022; 10():884349. PubMed ID: 35712294
[TBL] [Abstract][Full Text] [Related]
28. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract][Full Text] [Related]
29. A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.
Chen J; Wu L; Zhang Z; Zheng S; Lin Y; Ding N; Sun J; Shi L; Xue M
Cancer Med; 2021 Feb; 10(3):944-955. PubMed ID: 33350173
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2021; 9():831940. PubMed ID: 35155365
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of Novel Nomograms Using Serum Tumor Markers for the Prediction of Preoperative Histologic Grades in Gastroenteropancreatic Neuroendocrine Tumors.
Li Y; Wu ZQ; Xu Q; Goyal H; Xu HG
Front Oncol; 2021; 11():681149. PubMed ID: 34109127
[TBL] [Abstract][Full Text] [Related]
33. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
34. Gastroenteropancreatic neuroendocrine carcinoma in children and adolescents: a population-based study.
Lin W; Zhu Z; Shang Y
J Cancer Res Clin Oncol; 2024 Jan; 150(1):4. PubMed ID: 38168014
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms.
Huang PY; Tsai KL; Liang CM; Tai WC; Rau KM; Wu KL; Huang CC; Chuah SK
Kaohsiung J Med Sci; 2018 Nov; 34(11):650-656. PubMed ID: 30392572
[TBL] [Abstract][Full Text] [Related]
36. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.
Liu Z; Li G; Liu H; Zhu J; Wang D
Int J Clin Pract; 2022; 2022():8568724. PubMed ID: 36380749
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
Guo LJ; Wang CH; Tang CW
Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
[TBL] [Abstract][Full Text] [Related]
39. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
